Quest Diagnostics Inc logo

DGX - Quest Diagnostics Inc News Story

$127.07 0.3  0.2%

Last Trade - 31/07/20

Sector
Healthcare
Size
Large Cap
Market Cap £13.04bn
Enterprise Value £15.88bn
Revenue £5.75bn
Position in Universe 507th / 6362

BREAKINGVIEWS-U.S. testing firms aren’t having a great pandemic

Thu 4th June, 2020 6:57pm
(The author is a Reuters Breakingviews columnist. The opinions expressed are his own.) By Robert Cyran NEW YORK, June 4 (Reuters Breakingviews) - With no vaccine, finding Covid-19 cases is key. But it’s not lucrative. Extra revenue is being offset by falls in other tests for Quest and rival lab companies and in unrelated businesses for test makers like Abbott. There's little time to cash in and plenty of competition. Full view will be published shortly. On Twitter https://twitter.com/rob_cyran CONTEXT NEWS - More than 457,000 tests to diagnosis Covid-19 were performed in the United States on June 3 according to the Covid Tracking Project. - For previous columns by the author, Reuters customers can click on CYRAN/ - SIGN UP FOR BREAKINGVIEWS EMAIL ALERTS http://bit.ly/BVsubscribe <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Covid Tracking Project https://covidtracking.com/data/us-daily ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^> (Editing by Richard Beales and Amanda Gomez) ((robert.cyran@thomsonreuters.com; Reuters Messaging: robert.cyran.thomsonreuters.com@reuters.net))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.